Subject: 12 hours left

There's only 12 hours left to get this offer (and your free $50 credit). If you're going to act, now is the time...

 
Market Size Determination for the Cell Therapy CDMO Market

Among cell therapy companies, the pressure for manufacturing innovation and optimization can incentivize them to seek third-party partners who possess technical, manufacturing, and regulatory expertise, such as cell therapy contract and development manufacturing organizations (CDMOs).

Benefits of partnering with a cell therapy CDMO include scalability, speed to market, access to technical expertise without overhead costs, and cost efficiencies. With more than two dozen market participants now offering cell therapy CDMO services, demand for these services is clearly expanding.

For this reason, we released a 20 page market brief that defines the size of the Cell Therapy CDMO Market and provides future market projections.

It reveals the...
  • Top 3 market leaders (that control nearly 50% of the market share)
  • Relative size of each market participant
  • Size of the Cell Therapy CDMO Market
  • Projections for the Cell Therapy CDMO Market through 2022 

[Get it now...]


Enjoy,
The BioInformant Team


p.s. If you claim it within the next 12 hours, you will be emailed a code for a free $50 credit. You can use it to claim any product in our Shop, and if it is under $50, it will be yours for FREE. 

p.p.s. Questions about this offer? Hit "reply" to this email.








BIOINFORMANT | 800 Corporate Drive, Suite 301, Stafford, VA 22554, United States
You may unsubscribe or change your contact details at any time.